GSK : Q2 2023 results announcement
Results Summary Research and ...
Source: marketscreener.com
Stay updated with breaking news from Relvar Breo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This pharmaceutical company is growing revenue and profits from drugs it doesn't market or sell.
GSK delivers FY 2020 reported sales of £34 billion, +1% AER, +3% CER and Adjusted EPS of 115.9p, -6% AER, -4% CER, in line with guidance; Total EPS 115.5p, +23% AER Highlights Strong sales performance from key growth drivers in HIV, Respiratory, Oncology and Consumer Healthcare offset disruption from COVID-19 to adult vaccinations · Pharmaceuticals £17 billion -3% AER, -1% CER; new and specialty products £9.7 billion +11% AER, +12% CER · · · New ...